Sutro Biopharma Inc

Sutro Biopharma Inc

STRO

Get informed when a big investor buys or sells

+ Follow
Market Cap$245.61M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Sutro Biopharma IncSutro Biopharma Inc-1.5-230%3-0.3
$51.00

Target Price by Analysts

139.4% upsideSutro Biopharma Target Price DetailsTarget Price
$-0.82

Current Fair Value

103.8% downside

Overvalued by 103.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$245.61 Million
Enterprise Value$194.96 Million
Dividend Yield$- (-)
Earnings per Share$-22.49
Beta1.52
Outstanding Shares13,082,355

Return

Return on Equity229.64%ROE
Return on Assets-63.48%
Return on Invested Capital-68.36%

Valuation & Multiples

P/E Ratio-1.54P/E Ratio
PEG3.12PEG
Price to Sales3.04Price to Sales
Price to Book Ratio-3.55Price to Book Ratio
Enterprise Value to Revenue1.96
Enterprise Value to EBIT-1.67
Enterprise Value to Net Income-2
Total Debt to Enterprise0.12
Debt to Equity-0.34Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 10, 2026
EPS Estimate
$-2.55
Average shareholder expectation
Revenue Estimate
$9.93 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts61,400▲ Infinity%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %10774.37%▲ 6494.94%
Total Invested$351.11M▲ 441.87%
Investors Holding72▲ 11.00%

ESG Score

No data

About Sutro Biopharma Inc

CEO: William Newell